VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $204,112 | -10.6% | 7,585 | 0.0% | 0.18% | -8.1% |
| Q2 2023 | $228,384 | -6.9% | 7,585 | 0.0% | 0.20% | +27.9% |
| Q1 2023 | $245,375 | +10.0% | 7,585 | -2.6% | 0.15% | +6.2% |
| Q4 2022 | $223,000 | +4.7% | 7,785 | +0.0% | 0.14% | +1.4% |
| Q2 2022 | $213,000 | -28.8% | 7,784 | 0.0% | 0.14% | -15.9% |
| Q1 2022 | $299,000 | +18.2% | 7,784 | -1.3% | 0.17% | +23.2% |
| Q4 2021 | $253,000 | +9.1% | 7,884 | +0.0% | 0.14% | -0.7% |
| Q3 2021 | $232,000 | -13.8% | 7,883 | -0.3% | 0.14% | -14.7% |
| Q2 2021 | $269,000 | +4.7% | 7,903 | 0.0% | 0.16% | -3.6% |
| Q1 2021 | $257,000 | -10.8% | 7,903 | -1.2% | 0.17% | -18.4% |
| Q4 2020 | $288,000 | -12.7% | 8,003 | -5.2% | 0.21% | -21.3% |
| Q3 2020 | $330,000 | +8.2% | 8,438 | +1.4% | 0.26% | -1.9% |
| Q2 2020 | $305,000 | +30.9% | 8,318 | +4.7% | 0.27% | +29.5% |
| Q4 2019 | $233,000 | +10.4% | 7,947 | +0.4% | 0.21% | +4.5% |
| Q3 2019 | $211,000 | – | 7,917 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |